180 related articles for article (PubMed ID: 23069843)
1. Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis.
Cohen JB; Gordon CE; Balk EM; Francis JM
Transplantation; 2012 Nov; 94(10):1041-8. PubMed ID: 23069843
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia secondary to persistent hyperparathyroidism in kidney transplant patients: analysis after a year with cinacalcet.
Guerra R; Auyanet I; Fernández EJ; Pérez MÁ; Bosch E; Ramírez A; Suria S; Checa MD
J Nephrol; 2011; 24(1):78-82. PubMed ID: 20437396
[TBL] [Abstract][Full Text] [Related]
3. Cinacalcet in the treatment of persistent hyperparathyroidism after kidney transplantation.
Pinho LR; Ribeiro Santos MJ; Pestana Vasconcelos M
Clin Nephrol; 2011 Mar; 75(3):263-8. PubMed ID: 21329638
[TBL] [Abstract][Full Text] [Related]
4. Effects of cinacalcet in renal transplant patients with hyperparathyroidism.
Courbebaisse M; Diet C; Timsit MO; Mamzer MF; Thervet E; Noel LH; Legendre C; Friedlander G; Martinez F; Prié D
Am J Nephrol; 2012; 35(4):341-8. PubMed ID: 22473131
[TBL] [Abstract][Full Text] [Related]
5. Effect of cinacalcet cessation on hyperparathyroidism in kidney transcaplant patients after long-term dialysis therapy.
Nakai K; Fujii H; Yoshikawa M; Kono K; Yonekura Y; Goto S; Ishimura T; Takeda M; Fujisawa M; Nishi S
Clin Exp Nephrol; 2015 Dec; 19(6):1184-8. PubMed ID: 25782729
[TBL] [Abstract][Full Text] [Related]
6. Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials.
Palmer SC; Nistor I; Craig JC; Pellegrini F; Messa P; Tonelli M; Covic A; Strippoli GF
PLoS Med; 2013; 10(4):e1001436. PubMed ID: 23637579
[TBL] [Abstract][Full Text] [Related]
7. Development of nephrolithiasis in a renal transplant patient during treatment with Cinacalcet.
Seager CM; Srinivas TR; Flechner SM
Ann Transplant; 2013 Jan; 18():31-5. PubMed ID: 23792498
[TBL] [Abstract][Full Text] [Related]
8. Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up.
Paschoalin RP; Torregrosa JV; Sánchez-Escuredo A; Barros X; Durán CE; Campistol JM
Transplant Proc; 2012 Nov; 44(9):2588-9. PubMed ID: 23146463
[TBL] [Abstract][Full Text] [Related]
9. Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism.
Cho ME; Duan Z; Chamberlain CE; Reynolds JC; Ring MS; Mannon RB
Transplant Proc; 2010 Nov; 42(9):3554-8. PubMed ID: 21094814
[TBL] [Abstract][Full Text] [Related]
10. Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study.
Evenepoel P; Sprangers B; Lerut E; Bammens B; Claes K; Kuypers D; Meijers B; Vanrenterghem Y
Clin Transplant; 2012; 26(3):393-402. PubMed ID: 22007637
[TBL] [Abstract][Full Text] [Related]
11. Treatment with cinacalcet of secondary hyperparathyroidism after renal transplantation.
Gómez Marqués G; Obrador Mulet A; Vilar Gimeno A; Pascual Felip MJ; Alarcón Zurita A; Molina Guasch M; Uriol Rivera M; Munar Vila MA; Losada González P
Transplant Proc; 2009; 41(6):2139-43. PubMed ID: 19715856
[TBL] [Abstract][Full Text] [Related]
12. Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism.
Serra AL; Wuhrmann C; Wüthrich RP
Am J Kidney Dis; 2008 Dec; 52(6):1151-7. PubMed ID: 18950915
[TBL] [Abstract][Full Text] [Related]
13. Renal function in patients treated with cinacalcet for persistent hyperparathyroidism after kidney transplantation.
Henschkowski J; Bischoff-Ferrari HA; Wüthrich RP; Serra AL
Kidney Blood Press Res; 2011; 34(2):97-103. PubMed ID: 21273790
[TBL] [Abstract][Full Text] [Related]
14. [Retrospective assessment of effective and safety of cinacalcet for the treatment of secondary hyperparathyroidism depending on basal iPTH level].
Mercadal Orfila G; Blasco Mascaró I
Farm Hosp; 2012; 36(1):11-5. PubMed ID: 21514862
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia due to resistant hyperparathyroidism in renal transplant patients treated with the calcimimetic agent cinacalcet.
Apostolou T; Kollia K; Damianou L; Kaitsioti H; Kotsiev V; Dracopoulos S; Vougas V; Hadjiconstantinou V
Transplant Proc; 2006 Dec; 38(10):3514-6. PubMed ID: 17175318
[TBL] [Abstract][Full Text] [Related]
16. Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation.
Borchhardt KA; Heinzl H; Mayerwöger E; Hörl WH; Haas M; Sunder-Plassmann G
Transplantation; 2008 Oct; 86(7):919-24. PubMed ID: 18852656
[TBL] [Abstract][Full Text] [Related]
17. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism.
Szwarc I; Argilés A; Garrigue V; Delmas S; Chong G; Deleuze S; Mourad G
Transplantation; 2006 Sep; 82(5):675-80. PubMed ID: 16969292
[TBL] [Abstract][Full Text] [Related]
18. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism.
Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
Nephrol Dial Transplant; 2005 Jul; 20(7):1311-4. PubMed ID: 15941846
[TBL] [Abstract][Full Text] [Related]
19. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM
Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597
[TBL] [Abstract][Full Text] [Related]
20. Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet.
Apostolou T; Damianou L; Kotsiev V; Drakopoulos S; Hadjiconstantinou V
Clin Nephrol; 2006 May; 65(5):374-7. PubMed ID: 16724661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
